Homotypic fusion of early endosomes: SNAREs do not determine fusion specificity. by Brandhorst, D. et al.
Homotypic fusion of early endosomes: SNAREs do not
determine fusion specificity
Dorothea Brandhorst*, Daniel Zwilling*, Silvio O. Rizzoli*, Undine Lippert, Thorsten Lang, and Reinhard Jahn†
Department of Neurobiology, Max Planck Institute for Biophysical Chemistry, 37077 Go¨ttingen, Germany
Communicated by Thomas C. Su¨dhof, University of Texas Southwestern Medical Center, Dallas, TX, December 23, 2005 (received for review
December 4, 2005)
Membrane fusion in the secretory pathway is mediated by soluble
N-ethylmaleimide-sensitive factor attachment receptor (SNARE)
proteins. Different fusion steps are thought to be effected by
independent sets of SNAREs, but it is unclear whether specificity is
determined by an intrinsic specificity of SNARE pairing or by
upstream factors. Using a newly developed microscopy-based
assay, we have investigated the SNARE specificity of homotypic
early endosomal fusion. We show that early endosomes contain
multiple sets of SNAREs, including, in addition to the putative early
endosomal SNAREs, those involved in exocytosis and in fusion of
late endosomes. We demonstrate that fusion is largely mediated
by a complex formed by syntaxin 13, syntaxin 6, vti1a, and VAMP4,
whereas the exocytic and late endosomal SNAREs play little or no
role in the reaction. In contrast, proteoliposomes reconstituted
with early endosomal SNAREs promiscuously fuse with liposomes
containing exocytotic or late endosomal SNAREs. We conclude that
the specificity of SNARE pairing does not suffice to determine the
specificity of organelle fusion.
endocytosis  exocytosis  PC12 cells
Soluble N-ethylmaleimide (NEM)-sensitive factor attachmentreceptor (SNARE) proteins are represented by a superfamily
of small membrane-associated proteins that mediate membrane
fusion in the secretory pathway. All SNAREs possess a SNARE
motif that is usually flanked by a C-terminal transmembrane
domain (for recent reviews, see refs. 1–3). SNAREs assemble into
stable bundles of four -helices, forming coiled coils with the
transmembrane domains located at one end of the bundle (4–6).
Each helix is contributed by a different SNAREmotif belonging to
separate subfamilies, termedQa-, Qb-, Qc-, and R-SNAREmotifs,
respectively (7, 8). All functional SNARE complexes are thought to
contain one member of each subfamily (QabcR-rule), and, despite
limited sequence homologies, the structure of SNARE complexes
is highly conserved (6).
Assembly among SNAREs bridging the two fusing mem-
branes is considered to be the key step in membrane fusion. It
is probably initiated at the N terminus of the SNAREmotifs and
proceeds toward the C terminus (referred to as ‘‘zippering’’),
resulting in a strained ‘‘trans’’-complex. During membrane
merger, the intermediate relaxes into a ‘‘cis’’-complex in which
the transmembrane domains are aligned so that they are parallel
(1–3).
There are 25 SNAREs in yeast and 35 in mammals, and it
was proposed that the SNAREs directly encode the specificity of
organelle fusion (9–12). According to this view, each SNARE
complex functions in only one intracellular fusion step and pairs
only with its ‘‘cognate’’ binding partners. For instance, the
SNAREs involved in regulated exocytosis of neurons and neu-
roendocrine cells, including syntaxin 1 (Qa), soluble NSF at-
tachment protein (SNAP)-25 (Qbc), and synaptobrevin
VAMP2 (R), are thought to function exclusively in regulated
exocytosis. Similarly, unique SNARE complexes have been
assigned for most trafficking steps in yeast.
However, certain SNAREs function in multiple trafficking
steps, and some SNAREs are known to substitute for each other
(13–17). Which are the factors determining, for a given SNARE,
the fusion steps in which it operates and from which it is
excluded? In in vitro experiments involving soluble SNAREs,
little discrimination was observed between SNAREs of the same
subfamily in their capacity to form core complexes (18, 19).
However, experiments involving fusion of SNARE-containing
liposomes suggested a high degree of pairing specificity, raising
the possibility that SNARE pairing is much more specific when
the SNAREs are integrated in membranes (10–12).
In the present study, we have investigated the SNARE spec-
ificity of homotypic fusion of early endosomes from neurose-
cretory cells. Early (or sorting) endosomes are central relay
stations for membrane recycling. Early endosomes are con-
nected to late endosomes and lysosomes, to the Golgi apparatus,
and to the plasma membrane, and they are involved in recycling
of secretory and synaptic vesicles (20, 21). Consequently, the
early endosomes would contain not only the SNAREs involved
in homotypic fusion, but also SNAREs involved in fusion of the
organelles with which they interact. Thus, homotypic fusion of
early endosomes is suited as a model to investigate to which
extent the SNAREs involved in this fusion step are differentiated
from other SNAREs.
Homotypic fusion of early endosomes is one of the best-
characterized fusion reactions (22). Recognition, tethering, and
docking, the first steps in the reaction sequence, are orchestrated
by the small GTPase Rab5, which recruits a variety of effector
molecules (23–25). However, the identity of the SNARE pro-
teins responsible for early endosome fusion has not yet been
unambiguously determined. Proteins involved in Rab5-effector
complexes interact with syntaxin 13 (Qa), syntaxin 16 (Qa), and
syntaxin 6 (Qc). Furthermore, antibodies directed against syn-
taxin 13 inhibit fusion (26). Reports about a functional involve-
ment of syntaxin 6 are contradictory, however (27). Coimmu-
noprecipitation studies revealed an association between syntaxin
6, vti1a (Qb), and VAMP4 (R) and syntaxin 16 instead of
syntaxin 13 (28). In another set of immunoprecipitation exper-
iments, syntaxin 13 was found to be associated with synaptobre-
vin 2 (R) and SNAP-25 (Qbc) (29). Moreover, botulinum
neurotoxin E, which selectively cleaves SNAP-25, has recently
been reported to block early endosome fusion (29), whereas, in
an earlier study, cleavage of cellubrevin and synaptobrevin by
tetanus toxin had no effect (30).
Results
Characterization of an in Vitro Assay for Homotypic Fusion of Early
Endosomes.Tomeasure homotypic fusion of early endosomes, we
labeled two separate sets of PC12 cells for 5 min with dextrans
Conflict of interest statement: No conflicts declared.
Freely available online through the PNAS open access option.
Abbreviations: SNAP, soluble NEM-sensitive factor attachment protein; NEM, N-ethylma-
leimide; PNS, postnuclear supernatant; SNARE, soluble NEM-sensitive fusion attachment
receptor.
*D.B., D.Z., and S.O.R. contributed equally to this work.
†To whom correspondence should be addressed. E-mail: rjahn@gwdg.de.
© 2006 by The National Academy of Sciences of the USA








(10-kDa molecular mass) conjugated to the dyes Alexa 488 and
Alexa 594, respectively, as fluid phase markers. Postnuclear
supernatants (PNSs) were combined and incubated for the times
indicated, and the reaction was stopped by chilling on ice. Fused
endosomes were enriched by Nycodenz density gradient centrif-
ugation and then adsorbed on coverslips by low-speed centrif-
ugation (Fig. 6, which is published as supporting information on
the PNAS web site), followed by image analysis (Fig. 1a).
In vitro fusion of early endosomes is known to be ATP-
dependent, and numerous bright spots labeled with both dyes
were visible in the presence of ATP (Fig. 1b). The degree of
colocalization ranged from 7% to 27% in 80 independent
experiments, with much less variability in parallel experiments
performed on the same day (particles were scored as fused if
their intensity centers in the two channels were not 100 nm
apart, and all values were corrected for accidental colocaliza-
tion). No colocalization was observable in the absence of ATP.
Similar results were obtained with labeled transferrin, which is
selectively internalized via clathrin-coated vesicles (in three
independent experiments, 6–16% colocalization was observed in
the presence of ATP, and no colocalization was observed in the
absence of ATP). Fusion results in size increase of the organelles
(Fig. 1c). The size increase exceeded what would be expected if
each endosome would fuse only once, indicating multiple rounds
of fusion.
Fusion showed an almost linear increase within the first 10 min
and plateaued after1 h (Fig. 2a). Omission of rat brain cytosol
reduced fusion, and no fusion was observed even after prolonged
incubation on ice (Fig. 2b). Fusion was inhibited by the fast
Ca2-chelator 1,2-bis(2-aminophenoxy)ethane-N,N,N,N-
tetraacetate (Fig. 2c). These findings are in close agreement with
data obtained with a conventional content mixing assay (31–33).
Moreover, fusion was progressively inhibited by increasing con-
centrations of NEM (Fig. 2d), which is attributed to the inhibi-
tion of the NEM-sensitive factor (34). To confirm this finding,
we used a dominant negative variant of the cofactor -SNAP
(-SNAP L294A) (35). A dose-dependent inhibition of fusion
was observed, whereas wild-type -SNAP was ineffective
(Fig. 2e).
Localization of SNAREs on Early Endosomes. To localize SNAREs,
early endosomes were pulse-labeled and isolated as above, fixed,
and immunolabeled for a variety of SNAREs (Fig. 3). Not
surprisingly, there were many more immunoreactive organelles
than labeled endosomes. To determine the degree of colocal-
ization, linescans were performed after image alignment, fol-
lowed by correlation analysis (see Supporting Materials and
Methods, which is published as supporting information on the
PNAS web site, for details). Correlation coefficients of 1 rep-
resent complete colocalization, whereas correlation coefficients
of 0 represent independent distribution. As a positive control,
Fig. 1. Microscopic assay for measuring fusion of early endosomes from PC12
cells. (a) Schematic overview of the assay. (b) Representative micrographs of
fusion reactions (45 min of incubation) after adsorption of endosomes on
coverslips (green channel, dextran-Alexa 488; red channel, dextran-Alexa
594). Fusion assays were carried out in the presence of either an ATP-
regenerating system (ATP) or an ATP-depleting system (ATP). Images
acquired in the red and green channels were aligned by using fluorescent
beads (arrows) as reference. Fused endosomes are identified by colocalization
(yellow, circles). (c) Size distribution of labeled organelles after incubation for
45 min. Sizes of fused (black) and unfused (gray) organelles were measured by
linescan analysis (corrected for the point spread function, see Materials and
Methods for details), binned in 100-nm classes, and plotted as percentage of
total number (n  311 for each population).
Fig. 2. Characterization of early endosome fusion by using the microscopic
assay. (a) Time course of endosome fusion. Values are means  SEM of eight
independent experiments. Fusion is given as percentage of the 60-min value.
(b) Endosome fusion is accelerated when supplemented with rat brain cytosol
and is blocked at 0°C. Values are means SEM of eight (cytosol) or seven (ice)
independent experiments. (c) Endosome fusion is Ca2-dependent. Fusion
assays were performed in the presence of 5 mM or 10 mM 1,2-bis(2-
aminophenoxy)ethane-N,N,N,N-tetraacetate (BAPTA) as Ca2-chelator. Val-
ues are means SEM of 14 independent experiments. (d) NEM inhibits fusion
activity. Both PNSs and rat brain cytosol were preincubated separately with
indicated concentrations of NEM for 15 min on ice. Values are means of four
independent experiments. Error bars indicate the range of values. (e) Inhibi-
tion of endosome fusion by the dominant negative -SNAP mutant L294A.
PNS fractions were preincubated separately with the indicated concentrations
of -SNAP (L294A) or of wild-type -SNAP for 15 min on ice. Values are means
of two to four independent experiments. Error bars indicate the range of
values.
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two differently colored dextrans were cointernalized by the same
cells, resulting in a correlation coefficient of 0.97. Immunostain-
ing for the early endosomal SNARE candidates, including
syntaxin 13, syntaxin 16, vti1a, syntaxin 6, and VAMP4, resulted
in a high degree of colocalization, similar to the transferrin
receptor, a bona-fide resident of early endosomes (36). Similarly
high correlation coefficients were obtained for both exocytotic
and late endosomal SNAREs and for the synaptic vesicle protein
synaptophysin (Fig. 3c). In contrast, no correlation was observed
for sec 22 and use 1, two SNAREs operating in trafficking
between the endoplasmic reticulum and the Golgi apparatus,
although immunopositive organelles were of comparable abun-
dance (Fig. 3 a and c).
Inhibition of Early Endosome Fusion by Competition with Soluble
SNAREs. To investigate which SNAREs are involved in early
endosome fusion, we added recombinant soluble SNAREs to
compete with assembly of the endogenous SNAREs and thus
inhibit fusion (37). Inactive cis-complexes formed between en-
dogenous membrane-resident SNAREs and exogenously added
SNAREs are probably disassembled by NEM-sensitive fusion,
which counteracts inhibition; thus, sufficiently high concentra-
tions of the competing SNARE are required.
Fig. 4a shows the effects of the candidate early endosomal
Q-SNAREs, including the two Qa-SNAREs syntaxin 13 and 16,
the Qb-SNARE vti1a, and the Qc-SNARE syntaxin 6, either
alone or in various combinations. Inhibition was observed in all
cases. However, syntaxin 13 was consistently more potent than
syntaxin 16, and no additivity was observed. vti1a and syntaxin
6 caused partial inhibition, and a combination of vti1a, syntaxin
6, and syntaxin 13 almost abolished fusion. No such synergism
was observed with syntaxin 16, suggesting that syntaxin 16 does
not interact functionally with vti1a and syntaxin 6. In contrast,
the neuronal and late endosomal Q-SNAREs were largely
ineffective in inhibiting fusion (Fig. 4b). As an independent
means to exclude the SNAP-25 functions in early endosome
fusion (29), we treated the PNSs with the light chain of botuli-
num neurotoxin E, a SNAP-25-specific protease. No inhibition
was observed (Fig. 7, which is published as supporting informa-
tion on the PNAS web site).
We also tested eight different R-SNAREs (Fig. 4c). VAMP4
inhibited fusion to a higher level than all of the other candidates
(40% inhibition, P  0.001). Endobrevin resulted in only a
minor effect (14% inhibition, P  0.05), whereas synaptobre-
vin, cellubrevin, Ti-VAMP, VAMP5, Ykt6, and Sec22 failed to
elicit an inhibitory effect, despite some scatter in the results.
Combining endobrevin and VAMP4 did not result in a higher
block of fusion than that obtained with VAMP4 alone (data not
shown).
Fusion of Proteoliposomes Containing SNAREs.The results described
so far have established (i) that early endosomes contain at least
three complete sets of SNAREs and (ii) that only one of these
sets is mainly used for homotypic fusion. To test whether this
specificity is encoded by the SNAREs themselves, we performed
fusion experiments using liposomes coreconstituted with recom-
binant SNARE proteins. Previous work has established that
liposomes reconstituted with appropriate sets of SNAREs spon-
taneously fuse with each other and that fusion is associated with
the formation of SNARE core complexes (38).
Fusion was monitored by lipid dequenching (39). First, we
investigated whether liposomes containing all three early endo-
somal Q-SNAREs (syntaxin 13, syntaxin 6, and vti1a) fuse
exclusively with liposomes containing VAMP4 or whether they
are also capable of fusing with liposomes containing synapto-
brevin 2 and endobrevin. Robust fusion signals were observed in
each case (Fig. 5a); fusion was sensitive to competition by the
corresponding soluble R-SNARE. Fusion activity was observed
regardless of whether the Q- or R-SNARE liposomes were
labeled (Fig. 5a and data not shown). Similarly, liposomes
carrying neuronal Q-SNAREs fused equally well with liposomes
containing either endobrevin or synaptobrevin (data not shown).
Second, we investigated to what extent fusion of Q-SNARE
liposomes with VAMP4-containing liposomes is competed for
by soluble VAMP4, synaptobrevin, and endobrevin. Again, all
three R-SNAREs were capable of competing with fusion in a
similar concentration range (Fig. 5 b–d).
Discussion
In the present study we have identified the SNAREs syntaxin 13,
vti1a, syntaxin 6, and VAMP4 as the main SNAREs responsible
for homotypic fusion of early endosomes. Neither the SNAREs
involved in exocytosis nor the SNAREs involved in the fusion of
late endosomes participate to significant levels in the fusion
reaction, although both sets of SNAREs are abundantly present
Fig. 3. Localization of SNAREs on early endosomes by using immunocyto-
chemistry. (a) Fluorescence micrographs showing endosomes labeled with
dextran-Alexa 488 (green channel) immunostained for syntaxin 13 (Left) and
use 1 (Right) (red channel). To determine colocalization, linescans were per-
formed through the intensity centers of green endosomes (examples indi-
cated by white lines). (b) Representative linescan analysis, obtained from the
images shown in a, showing intensity profiles of green (endosomes) and red
(antibody-staining) signals. (c) Colocalization between early endosomes and
SNARE proteins as determined by linescan analysis and correlation (see Ma-
terials and Methods). A correlation coefficient of 1 represents complete
colocalization, whereas a correlation coefficient of0 represent independent
distribution. Coint, simultaneous labeling with dextran-Alexa 488 and dex-
tran-Alexa 594 (positive control); 2nd AB, omission of the primary antibody
(negative control); syphy, synaptophysin; syx, syntaxin; eb, endobrevin
VAMP8; -tub, -tubulin; tfr, transferrin receptor. Values are means of two
independent experiments with 60 analyzed endosomes each. Error bars indi-
cate the range of values.








on the organelles. In contrast, proteoliposomes reconstituted
with the same set of SNAREs promiscuously fuse with each
other, showing that the specificity of organelle fusion is not
determined by the specificity of SNARE pairing.
Our assay for early endosome fusion is more sensitive than
conventional content mixing assays, and it allows for performing
immunocytochemistry on isolated organelles. However, the per-
centage of fusion determined by particle counting is lower than
that determined by classical contents-mixing assays. This diver-
gence is to be expected because our assay does not discriminate
between single and multiple fusion events, with the latter
occurring abundantly, as demonstrated by the size increase
during fusion. We were unable to identify a dilution-resistant
state of the reaction, because dilution invariably caused an
immediate inhibition of fusion (D.B. and R.J., unpublished
observations). Moreover, attempts to define a docked but not
fused state by measuring adjacent but nonoverlapping dots were
not successful even when the putatively postdocking inhibitor
1,2-bis(2-aminophenoxy)ethane-N,N,N,N-tetraacetate was
used.
Previous studies have shown that cell-free fusion assays are
preferentially inhibited by cognate SNAREs although some
crosstalk between cognate and noncognate SNAREs was ob-
served. For instance, in cracked PC12 cells, exocytosis is more
sensitive to inhibition by synaptobrevinVAMP2 than by
VAMP7 and endobrevinVAMP8 (40). However, specificity
was not absolute because VAMP4 was almost as effective as
synaptobrevin. Similarly, syntaxin 4 was almost as potent in
inhibiting exocytosis as syntaxin 1, whereas several other syn-
taxins, including syntaxin 6, syntaxin 8, and syntaxin 13, were
Fig. 4. Effects of adding recombinant SNAREs on fusion of early endosomes.
(a) Effects of Q-SNAREs considered to be involved in the fusion of early
endosomes, including syntaxin 16 (syx 16), syntaxin 13 (syx 13), vti1a, and
syntaxin 6 (syx 6). Values are means SEM of 7–10 independent experiments.
(b) Effects of late endosomal and neuronal Q-SNAREs, including syntaxin 7 (syx
7), vti1b, syntaxin 8 (syx 8), syntaxin 1 (syx 1), and SNAP-25. Values are means
SEM of 7–13 independent experiments. (c) Effects of R-SNAREs, including
VAMP4, synaptobrevinVAMP2 (syb), endobrevinVAMP8 (eb), cellubrevin
VAMP3, Ti-VAMPVAMP7, VAMP5, ykt6, and sec22. Values are means SEM
of three to seven independent experiments. Individual Q-SNAREs were used at
12 M, with R-SNAREs tested at 25 M.
Fig. 5. Proteoliposomes containing the Q-SNAREs syntaxin 13, syntaxin 6,
and vti1a show no specificity for R-SNAREs in fusion. (a) Fusion with liposomes
containing VAMP4, endobrevin, or synaptobrevin. Fusion was monitored by
fluorescence dequenching due to dilution of labeled phospholipids with
unlabeled phospholipids during fusion (see Materials and Methods) and
normalized to maximal fluorescence measured after adding detergent at the
end of the reaction. As control, Q-SNARE liposomes were preincubated for 1 h
at room temperature with purified endobrevin or synaptobrevin lacking the
transmembrane domain (soluble fragment, final concentration of 30 M)
before starting the fusion reaction. (b–d) Dose-dependent inhibition by sol-
uble R-SNAREs of fusion between liposomes containing the Q-SNAREs syn-
taxin13, vti1a, and syntaxin 6 and liposomes containing the R-SNARE VAMP4.
Measurements were performed at 37°C with an overall protein concentration
of 3 M in the liposomes. The soluble R-SNAREs were added simultaneously
with the acceptor liposomes at the start of the reaction (concentrations
represent final assay concentrations).
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ineffective. In our hands, a higher degree of specificity was
observed. This observation closely agrees with the fact that the
early endosomes form a main sorting platform through which
many different SNAREs travel; accurate sorting probably relies
on effective mechanisms to select one set of SNAREs for the
homotypic fusion while silencing all others.
Our results show that the SNARE specificity of intracellular
fusion reactions is not controlled by their ability to form
complexes or by their ability to fuse liposomes, suggesting that
pairing specificity is not a main determinant for the specificity of
organelle fusion (at least in early endosome fusion). Rather, it is
likely that specificity is achieved by additional layers of control
that may involve regions outside the SNARE motif or the outer
surface of the helical SNARE motifs. Recently, it has been
shown that the SM protein Sly1p increases the specificity of
SNARE complex formation in the yeast endoplasmic reticulum-
to-Golgi SNARE complex (41), raising the possibility that SM
proteins are an integral part of the SNARE proofreading
mechanism. Another possibility is the direct interaction of
specific SNAREs with organelle-specific tethering factors, as
exemplified by the binding of syntaxin 13 and syntaxin 6 to EEA1
(27, 42). The contrast between the ability of recombinant
SNAREmotifs to inhibit endosome and liposome fusion asks for
mechanisms that differentiate between individual SNARE mo-
tifs of the same subclass, which remain to be identified.
Materials and Methods
Antibodies. The following antibodies were described previously:
rabbit sera specific for syntaxin 7 and syntaxin 8 (37), endobrevin
(18), and vti1b (43), mouse monoclonal antibodies specific for
synaptophysin Cl 7.2 (44), synaptobrevin Cl 69.1 (45), and
SNAP-25 Cl 71.1 (46) (all available from Synaptic Systems,
Go¨ttingen, Germany), and syntaxin 1 HPC-1 (47). Antibodies
for the transferrin receptor were obtained from Zymed, and
antibodies for -tubulin (TUJ1) were obtained from Babco
(Richmond, CA). Secondary antibodies (goat anti-rabbit and
goat anti-mouse, Cy3-labeled) were purchased from Jackson
ImmunoResearch.
Rabbit antisera were generated by using purified cytosolic parts
of VAMP4, syntaxin 6, syntaxin 13, and vti1a as antigens. All
antisera recognized single bands of the expected molecular mass in
immunoblots of PC12 cell homogenates (data not shown). Where
indicated, antibodies were affinity-purified by using the respective
purified proteins bound to CNBr-Sepharose (Amersham Pharma-
cia). Affinity-purified rabbit antibodies for the following proteins
were kind gifts: Sec 22, use 1 (S. Verrier, Max Planck Institute for
Biophysical Chemistry), and vti1b (G. Fischer von Mollard, Uni-
versity of Bielefeld, Bielefeld, Germany).
Molecular Cloning and Recombinant Proteins. Syntaxin 6 (residues
1–232) cDNA in pGEX vector was provided by R. H. Scheller
(Genentech, San Francisco) (48). The transmembrane region
was attached by PCR using standard procedures. Syntaxin 13
pGEX 1–232 (37) was subcloned in pET28a. DNA encoding
syntaxin 16 and Vti1a was provided by G. Fischer von Mollard
(28). cDNA encoding full-length VAMP4 (residues 1–141) was
amplified by RT-PCR using AccessQuick RT-PCR System kit
from Promega from a rat brain library (provided by S. Takamori,
Tokyo Medical and Dental University, Tokyo). All constructs
were subcloned into the pET28a vector. Each clone was verified
by DNA sequencing. For details, see Supporting Materials and
Methods.
Recombinant proteins were expressed as His6-tagged or GST-
tagged fusion proteins and purified by Ni2–agarose or gluta-
thione–Sepharose, respectively. The tags of all proteins were
removed by using thrombin cleavage. All proteins were further
purified by ion-exchange chromatography.
Syntaxin 7 (residues 1–236), vti1b (residues 1–206), syntaxin 8
(residues 1–213), and endobrevin (residues 1–74) were cloned,
expressed, and purified as described in ref. 37. Syntaxin 1a
(residues 1–262), SNAP-25a (residues 1–206), and synaptobre-
vinVAMP2 (residues 1–96) were described in refs. 18 and 49.
Wild-type -SNAP and -SNAP L294A (35) were provided by
D. Fasshauer (Max Planck Institute for Biophysical Chemistry).
Sec22 was provided by S. Verrier. VAMP5, ykt6, and sec22 were
used as GST-tagged constructs, with GST alone used as a negative
control. All proteins were 95% pure as judged by SDSPAGE and
Coomassie blue staining.
Cell Culture and Internalization of Marker. PC12 cells [clone 251
(50)] were grown to confluence on 15-cm-diameter culture
dishes in DMEM (with 5% FCS, 10% horse serum, 4 mM
glutamine, and 100 unitsml each of penicillin and streptomycin)
at 37°C in 10% CO2.
Cells were harvested by washing once with ice-cold PBS (150
mMNaCl200 mMNa2HPO4, pH 7.4), adding trypsinEDTA (2
ml per plate; Cambrex, East Rutherford, NJ). Fifteen confluent
plates resulted in a cell pellet of 2 ml volume. Cells were
washed with internalization medium (OptiMEM; Invitrogen,
supplemented with 10 mM glucose), prewarmed, and incubated
for 5 min with marker (10-kDa dextran labeled with Alexa 488
or Alexa 594, respectively; Molecular Probes) dissolved in in-
ternalization medium. After the internalization had been
stopped by diluting the cells in 10 ml of ice-cold PBS with 5
mgml BSA, the cells were washed three times.
Preparation of Subcellular Fractions and Rat Brain Cytosol.PC12 cells
were homogenized as described in ref. 33 with slight modifica-
tions. Briefly, the cell pellet was resuspended 1:4 in homogeni-
zation buffer (250 mM sucrose3 mM imidazoleHCl, pH 4.7)
with protease inhibitors (0.2 mM PMSF, 1 gml leupeptin, 1
gml aprotinin, and 0.7 gml pepstatin) and homogenized by
10 passages through a stainless-steel ball homogenizer with a
clearance of 0.0008 inch (20 m). The homogenates were
centrifuged for 15 min at 1,200	 g, and the resulting PNSs were
divided into aliquots and snap frozen in liquid N2. PNS fractions
labeled with Alexa 488 and Alexa 594 were used for the cell-free
fusion assay. Rat brain cytosol was prepared from fraction S2
(51) by centrifugation at 300,000 	 g for 30 min.
Cell-Free Fusion Assay. Reaction mixtures (50 l final volume)
contained, as final concentrations, 4 mgml PNSs, 2 mgml cytosol,
11.25 mMHepes at pH 7.0, 1.35 mMmagnesium acetate, 0.18 mM
DTT, 45 mM potassium acetate, as an ATP-regenerating system,
3.2 mM ATP, 26 mM creatine phosphate, and 0.132 mg creatine
kinase (800 unitsmg; Roche, Basel, Switzerland) or, as an ATP-
depleting system, 5 l of hexokinase (1,500 unitsml dissolved in
250 mM glucose; Roche). The reaction mixtures were incubated in
polycarbonate centrifuge tubes for 45 min at 37°C. After the
reaction had been stopped by cooling on ice, reactionmixtures were
overlaid with 100 l of ice-cold 30% Nycodenz solution [30%
Nycodenz (Nycomed Pharma, Unterschleissheim, Germany) in 0.5
mM EDTA3 mM imidazole, pH 7.4] and 100 l of ice-cold 12%
Nycodenz solution (12% Nycodenz in 0.5 mM EDTA3 mM
imidazole, pH 7.4) and then centrifuged for 90 min at 170,000 	 g
at 4°C. This purification step was necessary to reduce background
fluorescence in theAlexa 488 channel. After removal of the top 130
l, 10 l was harvested from the top of the remaining solution and
transferred into 1 ml of PBS on coverslips (18-mm diameter) in
12-well plates. After centrifugation for 2 h at 1,500 	 g at 4°C,
coverslips were analyzed with a fluorescence microscope (see
below). Before use of the coverslips, TetraSpeck beads (200-nm
diameter, dilution 1:100,000 in 1 ml PBS; Molecular Probes) were
bound to the surface by centrifugation for 1 h at 1,500 	 g.
For treatment with NEM, PNSs and cytosol were incubated
separately with indicated final concentrations of NEM for 15min








on ice. For the experiments presented in Fig. 4, PNS fractions
were preincubated with recombinant proteins for 15–20 min.
Coverslips were analyzed by using a Zeiss Axiovert 200M
fluorescence microscope with a 1.4 numerical aperture 	100
objective and appropriate filter sets. Several controls were
performed to ensure that the centrifugationadsorption steps
that followed the fusion reaction did not distort the results (see
Supporting Materials and Methods for details).
Size Determination of Early Endosomes. Fusion assays with ATP-
regenerating and -depleting systems were performed as de-
scribed above. Images were analyzed by using the linescan
function in METAMORPH (Universal Imaging,West Chester, PA).
Linescans with a width of 1 pixel and a length of 31 pixels were
performed through the intensity centers of 311 fused and
unfused endosomes, respectively. Values were corrected by the
point spread function that was experimentally defined by mea-
suring TetraSpeck beads of 200-nm size in the red and green
channel and divided into subclasses of 100-nm size.
Immunocytochemistry. PNSs obtained from labeled cells were in-
cubated by using an ATP-depleting system as described above.
Gradient centrifugation and adsorption to a glass coverslip were
carried out as above except that the coverslips were preincubated
with 10 mgml BSA overnight at 37°C. Adsorbed organelles were
fixed with 4% paraformaldehyde in PBS for 15 min, quenched for
15 min in PBS containing 50 mM NH4Cl, and washed two times
with PBS. Primary antibodies were used in a 1:100 dilution in PBS
containing 5% FCS for 1 h. Subsequently, endosomes were washed
three times with PBS for 10 min each, followed by incubation with
secondary antibodies (Cy 3-labeled, dilution 1:100 inPBS5%FCS)
for 45 min. After washing three times with PBS, coverslips were
imaged as described for the fusion assays.
Other Methods. Liposome preparation and liposome fusion assays
were performed as described in ref. 52, except that the Hepes
buffer contained 1 M KCl and further purification of liposomes
on Nycodenz-gradients was omitted. Liposomes were adjusted to
yield a final protein concentration of 3 M, and all fusion
experiments were carried out at 37°C. SDSPAGE and immu-
noblotting were performed as described in refs. 53 and 54, and
protein determination was performed according to ref. 55.
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